Evolution and transmission of drug resistant tuberculosis in a Russian population
暂无分享,去创建一个
Jukka Corander | Julian Parkhill | Sergey Nejentsev | Timothy Brown | Olga Ignatyeva | Simon R Harris | J. Corander | S. Nejentsev | J. Parkhill | S. Harris | J. Bryant | Y. Balabanova | F. Drobniewski | N. Casali | R. Horstmann | Vladyslav Nikolayevskyy | Francis Drobniewski | Yanina Balabanova | Nicola Casali | Irina Kontsevaya | T. Brown | Josephine Bryant | Rolf D Horstmann | V. Nikolayevskyy | I. Kontsevaya | O. Ignatyeva
[1] Daniel J. Wilson,et al. Whole-genome sequencing to delineate Mycobacterium tuberculosis outbreaks: a retrospective observational study , 2013, The Lancet. Infectious diseases.
[2] M. Nei. Molecular Evolutionary Genetics , 1987 .
[3] I. Mokrousov,et al. Mycobacterium tuberculosis Population in Northwestern Russia: An Update from Russian-EU/Latvian Border Region , 2012, PloS one.
[4] Gonçalo R. Abecasis,et al. The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..
[5] Sébastien Rodrigue,et al. Activation of the eis gene in a W-Beijing strain of Mycobacterium tuberculosis correlates with increased SigA levels and enhanced intracellular growth. , 2009, Microbiology.
[6] S. Niemann,et al. High Resolution Discrimination of Clinical Mycobacterium tuberculosis Complex Strains Based on Single Nucleotide Polymorphisms , 2012, PloS one.
[7] L. Via,et al. Mutations in gidB Confer Low-Level Streptomycin Resistance in Mycobacterium tuberculosis , 2011, Antimicrobial Agents and Chemotherapy.
[8] S. Borrell,et al. Strain diversity, epistasis and the evolution of drug resistance in Mycobacterium tuberculosis. , 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[9] Stephen D. Bentley,et al. Microevolution of extensively drug-resistant tuberculosis in Russia. , 2012, Genome research.
[10] F. Drobniewski,et al. Associations between Mycobacterium tuberculosis Strains and Phenotypes , 2010, Emerging infectious diseases.
[11] Olga Ignatyeva,et al. Survival of Civilian and Prisoner Drug-Sensitive, Multi- and Extensive Drug- Resistant Tuberculosis Cohorts Prospectively Followed in Russia , 2011, PloS one.
[12] M. Pai,et al. GenoType MTBDR assays for the diagnosis of multidrug-resistant tuberculosis: a meta-analysis , 2008, European Respiratory Journal.
[13] B. Barrell,et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence , 1998, Nature.
[14] Ying Zhang,et al. Mutations in pncA, a gene encoding pyrazinamidase/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus , 1996, Nature Medicine.
[15] Tim Brown,et al. Silent Nucleotide Polymorphisms and a Phylogeny for Mycobacterium tuberculosis , 2004, Emerging infectious diseases.
[16] Razvan Sultana,et al. Genomic Analysis Identifies Targets of Convergent Positive Selection in Drug Resistant Mycobacterium tuberculosis , 2013, Nature Genetics.
[17] Y. Balabanova,et al. Survival of drug resistant tuberculosis patients in Lithuania: retrospective national cohort study , 2011, BMJ Open.
[18] A. Zaha,et al. Streptomycin Resistance and Lineage-Specific Polymorphisms in Mycobacterium tuberculosis gidB Gene , 2011, Journal of Clinical Microbiology.
[19] Jukka Corander,et al. Identifying Currents in the Gene Pool for Bacterial Populations Using an Integrative Approach , 2009, PLoS Comput. Biol..
[20] Diarmaid Hughes,et al. Antibiotic resistance and its cost: is it possible to reverse resistance? , 2010, Nature Reviews Microbiology.
[21] Z. Udwadia. MDR, XDR, TDR tuberculosis: ominous progression , 2012, Thorax.
[22] L. Liljas,et al. Fitness‐compensatory mutations in rifampicin‐resistant RNA polymerase , 2012, Molecular microbiology.
[23] Marc Aumercier,et al. EthR, a repressor of the TetR/CamR family implicated in ethionamide resistance in mycobacteria, octamerizes cooperatively on its operator , 2003, Molecular microbiology.
[24] T. Sterling,et al. A systematic review of gyrase mutations associated with fluoroquinolone-resistant Mycobacterium tuberculosis and a proposed gyrase numbering system. , 2012, The Journal of antimicrobial chemotherapy.
[25] N. Colegrave,et al. Mutational neighbourhood and mutation supply rate constrain adaptation in Pseudomonas aeruginosa , 2010, Proceedings of the Royal Society B: Biological Sciences.
[26] J. Bayona,et al. Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis , 2010, The Lancet.
[27] W. Bishai,et al. Fluoroquinolones, tuberculosis, and resistance. , 2003, The Lancet. Infectious diseases.
[28] Stefan Niemann,et al. Whole-genome sequencing of rifampicin-resistant Mycobacterium tuberculosis strains identifies compensatory mutations in RNA polymerase genes , 2011 .
[29] James J. Cai. PGEToolbox: A Matlab toolbox for population genetics and evolution. , 2008, The Journal of heredity.
[30] M G Reynolds,et al. Compensatory evolution in rifampin-resistant Escherichia coli. , 2000, Genetics.
[31] Ted Cohen,et al. The effect of drug resistance on the fitness of Mycobacterium tuberculosis. , 2003, The Lancet. Infectious diseases.
[32] Jukka Corander,et al. Enhanced Bayesian modelling in BAPS software for learning genetic structures of populations , 2008, BMC Bioinformatics.
[33] Kai Ye,et al. Pindel: a pattern growth approach to detect break points of large deletions and medium sized insertions from paired-end short reads , 2009, Bioinform..
[34] Jukka Corander,et al. Hierarchical and Spatially Explicit Clustering of DNA Sequences with BAPS Software , 2013, Molecular biology and evolution.
[35] P. V. van Helden,et al. Putative Compensatory Mutations in the rpoC Gene of Rifampin-Resistant Mycobacterium tuberculosis Are Associated with Ongoing Transmission , 2012, Antimicrobial Agents and Chemotherapy.
[36] Stefan Niemann,et al. Variable host-pathogen compatibility in Mycobacterium tuberculosis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[37] A. Telenti,et al. Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis , 1993, The Lancet.
[38] Thomas Ludwig,et al. A fast program for maximum likelihood-based inference of large phylogenetic trees , 2004, SAC '04.
[39] Thomas Ludwig,et al. RAxML-III: a fast program for maximum likelihood-based inference of large phylogenetic trees , 2005, Bioinform..
[40] M. Kruijshaar,et al. Tuberculosis in the UK: Annual report on tuberculosis surveillance in the UK, 2009. , 2009 .
[41] S. Cole,et al. Effect of katG Mutations on the Virulence of Mycobacterium tuberculosis and the Implication for Transmission in Humans , 2002, Infection and Immunity.
[42] S. Cole,et al. The catalase—peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis , 1992, Nature.
[43] S. Svenson,et al. Spread of Drug-Resistant Pulmonary Tuberculosis in Estonia , 2001, Journal of Clinical Microbiology.
[44] Julian Parkhill,et al. Bacterial epidemiology and biology - lessons from genome sequencing , 2011, Genome Biology.
[45] P HAUDUROY,et al. MYCOBACTERIA: LABORATORY METHODS FOR TESTING DRUG SENSITIVITY AND RESISTANCE. , 1963, Bulletin of the World Health Organization.
[46] W. Jacobs,et al. inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. , 1994, Science.
[47] F. Schmidt. Meta-Analysis , 2008 .
[48] Ziheng Yang. PAML 4: phylogenetic analysis by maximum likelihood. , 2007, Molecular biology and evolution.
[49] Brian G. Williams,et al. Erasing the World's Slow Stain: Strategies to Beat Multidrug-Resistant Tuberculosis , 2002, Science.
[50] J. T. Crawford,et al. ethA, inhA, and katG Loci of Ethionamide-Resistant Clinical Mycobacterium tuberculosis Isolates , 2003, Antimicrobial Agents and Chemotherapy.
[51] B. Metchock,et al. Overexpression of the chromosomally encoded aminoglycoside acetyltransferase eis confers kanamycin resistance in Mycobacterium tuberculosis , 2009, Proceedings of the National Academy of Sciences.
[52] Q. Gao,et al. Association between embB Codon 306 Mutations and Drug Resistance in Mycobacterium tuberculosis , 2007, Antimicrobial Agents and Chemotherapy.
[53] Sang-Nae Cho,et al. Mycobacterium tuberculosis Eis Regulates Autophagy, Inflammation, and Cell Death through Redox-dependent Signaling , 2010, PLoS pathogens.
[54] E. Böttger,et al. Molecular basis of streptomycin resistance in Mycobacterium tuberculosis: alterations of the ribosomal protein S12 gene and point mutations within a functional 16S ribosomal RNA pseudoknot , 1993, Molecular microbiology.
[55] Y. Balabanova,et al. Multidrug-resistant tuberculosis in Russia: clinical characteristics, analysis of second-line drug resistance and development of standardized therapy , 2005, European Journal of Clinical Microbiology and Infectious Diseases.
[56] E. Böttger,et al. Tuberculosis: drug resistance, fitness, and strategies for global control , 2008, European Journal of Pediatrics.
[57] Thomas M. Shinnick,et al. Molecular Analysis of Cross-Resistance to Capreomycin, Kanamycin, Amikacin, and Viomycin in Mycobacterium tuberculosis , 2005, Antimicrobial Agents and Chemotherapy.
[58] J. Musser,et al. Molecular Genetic Analysis of Nucleotide Polymorphisms Associated with Ethambutol Resistance in Human Isolates ofMycobacterium tuberculosis , 2000, Antimicrobial Agents and Chemotherapy.
[59] Julian Parkhill,et al. Evolution of MRSA During Hospital Transmission and Intercontinental Spread , 2010, Science.
[60] M. DePristo,et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data , 2011, Nature Genetics.
[61] F. Drobniewski,et al. Evaluation of MGIT 960-Based Antimicrobial Testing and Determination of Critical Concentrations of First- and Second-Line Antimicrobial Drugs with Drug-Resistant Clinical Strains of Mycobacterium tuberculosis , 2006, Journal of Clinical Microbiology.
[62] Clifton E. Barry,et al. Compensatory ahpC Gene Expression in Isoniazid-Resistant Mycobacterium tuberculosis , 1996, Science.
[63] Y. Balabanova,et al. Drug-resistant tuberculosis, clinical virulence, and the dominance of the Beijing strain family in Russia. , 2005, JAMA.
[64] D van Soolingen,et al. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology , 1997, Journal of clinical microbiology.
[65] Dongfang Li,et al. Genome sequencing of 161 Mycobacterium tuberculosis isolates from China identifies genes and intergenic regions associated with drug resistance , 2013, Nature Genetics.